Sanctuary Advisors LLC Invests $85,000 in GoodRx Holdings, Inc. (NASDAQ:GDRX)

Sanctuary Advisors LLC acquired a new stake in shares of GoodRx Holdings, Inc. (NASDAQ:GDRX) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 12,273 shares of the company’s stock, valued at approximately $85,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. nVerses Capital LLC bought a new stake in shares of GoodRx during the 3rd quarter valued at about $33,000. Plato Investment Management Ltd bought a new stake in GoodRx during the second quarter valued at approximately $43,000. EP Wealth Advisors LLC purchased a new position in GoodRx in the 3rd quarter worth approximately $73,000. Dark Forest Capital Management LP bought a new position in shares of GoodRx in the 2nd quarter worth $86,000. Finally, Quest Partners LLC purchased a new stake in shares of GoodRx during the 3rd quarter valued at $160,000. 63.77% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on GDRX shares. Mizuho initiated coverage on GoodRx in a research note on Wednesday, December 4th. They issued a “neutral” rating and a $5.00 target price on the stock. Morgan Stanley dropped their target price on GoodRx from $7.00 to $6.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 17th. Barclays reduced their price target on shares of GoodRx from $10.00 to $6.00 and set an “overweight” rating on the stock in a research report on Monday, November 11th. Finally, Citigroup cut their price objective on shares of GoodRx from $10.00 to $7.00 and set a “buy” rating for the company in a research note on Wednesday, November 13th. One analyst has rated the stock with a sell rating, five have issued a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $8.37.

GoodRx Price Performance

Shares of GDRX stock opened at $4.51 on Tuesday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 5.48 and a current ratio of 5.48. GoodRx Holdings, Inc. has a fifty-two week low of $4.09 and a fifty-two week high of $9.26. The firm has a market cap of $1.72 billion, a P/E ratio of -150.33, a P/E/G ratio of 3.54 and a beta of 1.29. The business’s 50 day moving average price is $5.09 and its 200-day moving average price is $6.81.

GoodRx Profile

GoodRx Holdings, Inc, together with its subsidiaries, offers information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices.